First Trust Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,178
Closed -$1.39M 2554
2024
Q3
$1.39M Sell
14,178
-22,317
-61% -$2.88M ﹤0.01% 1914
2024
Q2
$5.97M Buy
36,495
+34,864
+2,138% +$4.97M 0.01% 1192
2024
Q1
$249K Sell
1,631
-24,199
-94% -$4.03M ﹤0.01% 2253
2023
Q4
$8.1M Buy
25,830
+9,665
+60% +$3.5M 0.01% 1066
2023
Q3
$7.18M Sell
16,165
-33,798
-68% -$15.3M 0.01% 1080
2023
Q2
$21.7M Buy
49,963
+36,340
+267% +$20.4M 0.02% 726
2023
Q1
$8.09M Sell
13,623
-34,162
-71% -$19.1M 0.01% 1046
2022
Q4
$19.3M Buy
47,785
+20,264
+74% +$9.5M 0.02% 731
2022
Q3
$16.1M Buy
+27,521
New +$16.5M 0.02% 778
2021
Q3
Sell
-8,058
Closed -$8.17M 2507
2021
Q2
$8.17M Buy
+8,058
New +$7.06M 0.01% 1071

Other funds holding AGL

First Trust Advisors's AGL Position: Q4 2024 in Review

First Trust Advisors sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 14,178 shares — an estimated $1.39M sold.

First Trust Advisors first reported a position in AGL in Q2 2021 and held it in 10 quarters. The position peaked at $21.7M in Q2 2023. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.

  • First Trust Advisors reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
  • First Trust Advisors sold 14,178 Agilon Health shares in Q4 2024, an estimated $1.39M.
  • First Trust Advisors first reported a position in Agilon Health in Q2 2021 and held it in 10 quarters.
  • First Trust Advisors's Agilon Health position peaked at $21.7M in Q2 2023.
  • 184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.

Based on First Trust Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.